[Billing Code: 4140-01-P]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby
given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational Sciences Special Emphasis
Panel Preclinical Proof of Concept Studies for Rare Diseases (R21) Review Meeting
Date: October 10-11, 2024
Time: 9:30 AM to 12:00 PM
Agenda: To review and evaluate grant applications
Place: National Center for Advancing Translational Sciences
National Institutes of Health
9609 Medical Center Drive
Rockville, MD 20892
(Virtual)
Contact Person: Carol (Chang-Sook) Kim, PHD
Scientific Review Administrator
Scientific Review Branch
Division of Extramural Activities
6701 Democracy Blvd

Bethesda, MD 20892
(301) 402-1744
carol.kim@nih.gov
(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology,
and Biological Chemistry Research; 93.350, B - Cooperative Agreements; 93.859, Biomedical
Research and Research Training, National Institutes of Health, HHS)
Dated: June 21, 2024.
David W. Freeman,
Supervisory Program Analyst,
Office of Federal Advisory Committee Policy.
[FR Doc. 2024-14151 Filed: 6/26/2024 8:45 am; Publication Date: 6/27/2024]